YM
Y-mAbs
YMAB·NASDAQNew York NYFounded 2015250 employees
Small CapbiotechPublicOncology
Platform: Anti-GD2
Market Cap
$0.6B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (YMAB)
Loading YMAB stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Capirelsin | YMA-677 | Phase 2 | 1 | FLT3 | FSGSBladder Ca | ||
| Zoriosocimab | YMA-1024 | Phase 3 | 2 | BCL-2 | Ewing Sarcoma |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)